List of Tables
Table 1. Hemostatic Agents CAGR in Value, India VS Global, 2018 VS 2022 VS 2029
Table 2. Hemostatic Agents Market Trends
Table 3. Hemostatic Agents Market Drivers
Table 4. Hemostatic Agents Market Challenges
Table 5. Hemostatic Agents Market Restraints
Table 6. Global Hemostatic Agents Sales Growth Rate (CAGR) by Type: 2018 VS 2022 VS 2029 (US$ Million)
Table 7. India Hemostatic Agents Sales Growth Rate (CAGR) by Type: 2018 VS 2022 VS 2029 (US$ Million)
Table 8. Global Hemostatic Agents Sales Growth Rate (CAGR) by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 9. India Hemostatic Agents Sales Growth Rate (CAGR) by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 10. Global Key Manufacturers of Hemostatic Agents, Ranked by Revenue (2022) & (US$ Million)
Table 11. Global Hemostatic Agents Revenue by Manufacturer, (US$ Million), 2018-2023
Table 12. Global Hemostatic Agents Revenue Share by Manufacturer, 2018-2023
Table 13. Global Hemostatic Agents Sales by Manufacturer, (K Units), 2018-2023
Table 14. Global Hemostatic Agents Sales Share by Manufacturer, 2018-2023
Table 15. Global Hemostatic Agents Price by Manufacturer (2018-2023) & (USD/Unit)
Table 16. Global Hemostatic Agents Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Hemostatic Agents by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hemostatic Agents as of 2022)
Table 18. Global Key Manufacturers of Hemostatic Agents, Manufacturing Base Distribution and Headquarters
Table 19. Global Key Manufacturers of Hemostatic Agents, Product Offered and Application
Table 20. Global Key Manufacturers of Hemostatic Agents, Date of Enter into This Industry
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Key Players of Hemostatic Agents in India, Ranked by Revenue (2022) & (US$ million)
Table 23. India Hemostatic Agents Revenue by Players, (US$ Million), (2018-2023)
Table 24. India Hemostatic Agents Revenue Share by Players, (2018-2023)
Table 25. India Hemostatic Agents Sales by Players, (K Units), (2018-2023)
Table 26. India Hemostatic Agents Sales Share by Players, (2018-2023)
Table 27. Global Hemostatic Agents Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 28. Global Hemostatic Agents Sales in Volume by Region (2018-2023) & (K Units)
Table 29. Global Hemostatic Agents Sales in Volume Forecast by Region (2024-2029) & (K Units)
Table 30. Global Hemostatic Agents Sales in Value by Region (2018-2023) & (US$ Million)
Table 31. Global Hemostatic Agents Sales in Value Forecast by Region (2024-2029) & (US$ Million)
Table 32. Americas Hemostatic Agents Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 33. Americas Hemostatic Agents Sales in Value by Country (2018-2023) & (US$ Million)
Table 34. Americas Hemostatic Agents Sales in Value by Country (2024-2029) & (US$ Million)
Table 35. Americas Hemostatic Agents Sales in Volume by Country (2018-2023) & (K Units)
Table 36. Americas Hemostatic Agents Sales in Volume by Country (2024-2029) & (K Units)
Table 37. EMEA Hemostatic Agents Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. EMEA Hemostatic Agents Sales in Value by Country (2018-2023) & (US$ Million)
Table 39. EMEA Hemostatic Agents Sales in Value by Country (2024-2029) & (US$ Million)
Table 40. EMEA Hemostatic Agents Sales in Volume by Country (2018-2023) & (K Units)
Table 41. EMEA Hemostatic Agents Sales in Volume by Country (2024-2029) & (K Units)
Table 42. APAC Hemostatic Agents Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. APAC Hemostatic Agents Sales in Value by Country (2018-2023) & (US$ Million)
Table 44. APAC Hemostatic Agents Sales in Value by Country (2024-2029) & (US$ Million)
Table 45. APAC Hemostatic Agents Sales in Volume by Country (2018-2023) & (K Units)
Table 46. APAC Hemostatic Agents Sales in Volume by Country (2024-2029) & (K Units)
Table 47. Ethicon Company Information
Table 48. Ethicon Description and Business Overview
Table 49. Ethicon Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 50. Ethicon Hemostatic Agents Product
Table 51. Ethicon Recent Development
Table 52. Pfizer Company Information
Table 53. Pfizer Description and Business Overview
Table 54. Pfizer Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 55. Pfizer Hemostatic Agents Product
Table 56. Pfizer Recent Development
Table 57. Baxter International Company Information
Table 58. Baxter International Description and Business Overview
Table 59. Baxter International Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 60. Baxter International Hemostatic Agents Product
Table 61. Baxter International Recent Development
Table 62. C. R. Bard Company Information
Table 63. C. R. Bard Description and Business Overview
Table 64. C. R. Bard Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 65. C. R. Bard Hemostatic Agents Product
Table 66. C. R. Bard Recent Development
Table 67. The Medicines Company Company Information
Table 68. The Medicines Company Description and Business Overview
Table 69. The Medicines Company Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 70. The Medicines Company Hemostatic Agents Product
Table 71. The Medicines Company Recent Development
Table 72. Anika Therapeutics Company Information
Table 73. Anika Therapeutics Description and Business Overview
Table 74. Anika Therapeutics Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 75. Anika Therapeutics Hemostatic Agents Product
Table 76. Anika Therapeutics Recent Development
Table 77. Advanced Medical Solutions Company Information
Table 78. Advanced Medical Solutions Description and Business Overview
Table 79. Advanced Medical Solutions Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 80. Advanced Medical Solutions Hemostatic Agents Product
Table 81. Advanced Medical Solutions Recent Development
Table 82. Integra LifeSciences Company Information
Table 83. Integra LifeSciences Description and Business Overview
Table 84. Integra LifeSciences Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 85. Integra LifeSciences Hemostatic Agents Product
Table 86. Integra LifeSciences Recent Development
Table 87. B Braun Melsungen Company Information
Table 88. B Braun Melsungen Description and Business Overview
Table 89. B Braun Melsungen Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 90. B Braun Melsungen Hemostatic Agents Product
Table 91. B Braun Melsungen Recent Development
Table 92. Gelita Medical Company Information
Table 93. Gelita Medical Description and Business Overview
Table 94. Gelita Medical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 95. Gelita Medical Hemostatic Agents Product
Table 96. Gelita Medical Recent Development
Table 97. Equimedical Company Information
Table 98. Equimedical Description and Business Overview
Table 99. Equimedical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 100. Equimedical Hemostatic Agents Product
Table 101. Equimedical Recent Development
Table 102. Vascular Solutions Company Information
Table 103. Vascular Solutions Description and Business Overview
Table 104. Vascular Solutions Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 105. Vascular Solutions Hemostatic Agents Product
Table 106. Vascular Solutions Recent Development
Table 107. Marine Polymer Technologies Company Information
Table 108. Marine Polymer Technologies Description and Business Overview
Table 109. Marine Polymer Technologies Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 110. Marine Polymer Technologies Hemostatic Agents Product
Table 111. Marine Polymer Technologies Recent Development
Table 112. Z-Medica Company Information
Table 113. Z-Medica Description and Business Overview
Table 114. Z-Medica Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 115. Z-Medica Hemostatic Agents Product
Table 116. Z-Medica Recent Development
Table 117. CryoLife Company Information
Table 118. CryoLife Description and Business Overview
Table 119. CryoLife Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 120. CryoLife Hemostatic Agents Product
Table 121. CryoLife Recent Development
Table 122. BioCer Entwicklungs Company Information
Table 123. BioCer Entwicklungs Description and Business Overview
Table 124. BioCer Entwicklungs Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 125. BioCer Entwicklungs Hemostatic Agents Product
Table 126. BioCer Entwicklungs Recent Development
Table 127. Biom’Up SAS Company Information
Table 128. Biom’Up SAS Description and Business Overview
Table 129. Biom’Up SAS Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 130. Biom’Up SAS Hemostatic Agents Product
Table 131. Biom’Up SAS Recent Development
Table 132. Key Raw Materials Lists
Table 133. Raw Materials Key Suppliers Lists
Table 134. Hemostatic Agents Customers List
Table 135. Hemostatic Agents Distributors List
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Hemostatic Agents Product Picture
Figure 2. Global Hemostatic Agents Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 3. Global Hemostatic Agents Market Size 2018-2029 (US$ Million)
Figure 4. Global Hemostatic Agents Sales 2018-2029 (K Units)
Figure 5. India Hemostatic Agents Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 6. India Hemostatic Agents Market Size 2018-2029 (US$ Million)
Figure 7. India Hemostatic Agents Sales 2018-2029 (K Units)
Figure 8. India Hemostatic Agents Market Share in Global, in Value (US$ Million) 2018-2029
Figure 9. India Hemostatic Agents Market Share in Global, in Volume (K Units) 2018-2029
Figure 10. Hemostatic Agents Report Years Considered
Figure 11. Product Picture of Gelation Sponge
Figure 12. Product Picture of Oxidized Regenerated Cellulose Based Hemostats
Figure 13. Product Picture of Others
Figure 14. Global Hemostatic Agents Market Share by Type in 2022 & 2029
Figure 15. Global Hemostatic Agents Sales in Value by Type (2018-2029) & (US$ Million)
Figure 16. Global Hemostatic Agents Sales Market Share in Value by Type (2018-2029)
Figure 17. Global Hemostatic Agents Sales by Type (2018-2029) & (K Units)
Figure 18. Global Hemostatic Agents Sales Market Share in Volume by Type (2018-2029)
Figure 19. Global Hemostatic Agents Price by Type (2018-2029) & (USD/Unit)
Figure 20. India Hemostatic Agents Market Share by Type in 2022 & 2029
Figure 21. India Hemostatic Agents Sales in Value by Type (2018-2029) & (US$ Million)
Figure 22. India Hemostatic Agents Sales Market Share in Value by Type (2018-2029)
Figure 23. India Hemostatic Agents Sales by Type (2018-2029) & (K Units)
Figure 24. India Hemostatic Agents Sales Market Share in Volume by Type (2018-2029)
Figure 25. India Hemostatic Agents Price by Type (2018-2029) & (USD/Unit)
Figure 26. Product Picture of Hospitals
Figure 27. Product Picture of Surgical Centers
Figure 28. Product Picture of Nursing Homes
Figure 29. Global Hemostatic Agents Market Share by Application in 2022 & 2029
Figure 30. Global Hemostatic Agents Sales in Value by Application (2018-2029) & (US$ Million)
Figure 31. Global Hemostatic Agents Sales Market Share in Value by Application (2018-2029)
Figure 32. Global Hemostatic Agents Sales by Application (2018-2029) & (K Units)
Figure 33. Global Hemostatic Agents Sales Market Share in Volume by Application (2018-2029)
Figure 34. Global Hemostatic Agents Price by Application (2018-2029) & (USD/Unit)
Figure 35. India Hemostatic Agents Market Share by Application in 2022 & 2029
Figure 36. India Hemostatic Agents Sales in Value by Application (2018-2029) & (US$ Million)
Figure 37. India Hemostatic Agents Sales Market Share in Value by Application (2018-2029)
Figure 38. India Hemostatic Agents Sales by Application (2018-2029) & (K Units)
Figure 39. India Hemostatic Agents Sales Market Share in Volume by Application (2018-2029)
Figure 40. India Hemostatic Agents Price by Application (2018-2029) & (USD/Unit)
Figure 41. Americas Hemostatic Agents Sales in Volume Growth Rate 2018-2029 (K Units)
Figure 42. Americas Hemostatic Agents Sales in Value Growth Rate 2018-2029 (US$ Million)
Figure 43. Americas Hemostatic Agents Sales by Type (2018-2029) & (K Units)
Figure 44. Americas Hemostatic Agents Sales Market Share in Volume by Type (2018-2029)
Figure 45. Americas Hemostatic Agents Sales by Application (2018-2029) & (K Units)
Figure 46. Americas Hemostatic Agents Sales Market Share in Volume by Application (2018-2029)
Figure 47. United States Hemostatic Agents Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 48. Canada Hemostatic Agents Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 49. Mexico Hemostatic Agents Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 50. Brazil Hemostatic Agents Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 51. EMEA Hemostatic Agents Sales in Volume Growth Rate 2018-2029 (K Units)
Figure 52. EMEA Hemostatic Agents Sales in Value Growth Rate 2018-2029 (US$ Million)
Figure 53. EMEA Hemostatic Agents Sales by Type (2018-2029) & (K Units)
Figure 54. EMEA Hemostatic Agents Sales Market Share in Volume by Type (2018-2029)
Figure 55. EMEA Hemostatic Agents Sales by Application (2018-2029) & (K Units)
Figure 56. EMEA Hemostatic Agents Sales Market Share in Volume by Application (2018-2029)
Figure 57. Europe Hemostatic Agents Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 58. Middle East Hemostatic Agents Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 59. Africa Hemostatic Agents Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 60. China Hemostatic Agents Sales in Volume Growth Rate 2018-2029 (K Units)
Figure 61. China Hemostatic Agents Sales in Value Growth Rate 2018-2029 (US$ Million)
Figure 62. China Hemostatic Agents Sales by Type (2018-2029) & (K Units)
Figure 63. China Hemostatic Agents Sales Market Share in Volume by Type (2018-2029)
Figure 64. China Hemostatic Agents Sales by Application (2018-2029) & (K Units)
Figure 65. China Hemostatic Agents Sales Market Share in Volume by Application (2018-2029)
Figure 66. APAC Hemostatic Agents Sales in Volume Growth Rate 2018-2029 (K Units)
Figure 67. APAC Hemostatic Agents Sales in Value Growth Rate 2018-2029 (US$ Million)
Figure 68. APAC Hemostatic Agents Sales by Type (2018-2029) & (K Units)
Figure 69. APAC Hemostatic Agents Sales Market Share in Volume by Type (2018-2029)
Figure 70. APAC Hemostatic Agents Sales by Application (2018-2029) & (K Units)
Figure 71. APAC Hemostatic Agents Sales Market Share in Volume by Application (2018-2029)
Figure 72. Japan Hemostatic Agents Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 73. South Korea Hemostatic Agents Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 74. China Taiwan Hemostatic Agents Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 75. Southeast Asia Hemostatic Agents Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 76. India Hemostatic Agents Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 77. Hemostatic Agents Value Chain
Figure 78. Hemostatic Agents Production Process
Figure 79. Channels of Distribution
Figure 80. Distributors Profiles
Figure 81. Bottom-up and Top-down Approaches for This Report
Figure 82. Data Triangulation
Figure 83. Key Executives Interviewed
